Pacira BioSciences logo
Pacira BioSciences
PCRX | NASDAQ
Chart Builder DCF Calculator
$36.48
+$0.02 (+0.05%)
At close: Nov 16, 2026, 4:00 PM ET
$36.48
+$0.01 (+0.01%)
After-hours: Nov 16, 2026, 7:30 PM ET

Pacira BioSciences Company Profile

Company profile explained

Company Profile

Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine suspension, and ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide. Furthermore, the company offers the iovera system, a non-opioid, handheld cryoanalgesia device capable of delivering precisely controlled cold temperatures to targeted nerves. Pacira also develops its unique multivesicular liposome (MVL) drug delivery technology, which encapsulates therapeutic compounds while preserving their inherent molecular structure. Established in 2006, the firm was formerly known as Pacira Pharmaceuticals, Inc. until its name change to Pacira BioSciences, Inc. in April 2019. Its main corporate office is situated in Tampa, Florida.

Key Executives

Name Position
Frank D. Lee Chief Executive Officer & Director
Shawn Cross Chief Financial Officer
Anthony Molloy Chief Legal & Compliance Officer
Brendan Teehan Chief Commercial Officer
Christopher C. Young Chief Manufacturing Officer
Jonathan Slonin Chief Medical Officer
Kristen Williams Chief Administrative Officer & Secretary
Krys Corbett Chief Business Officer
Lauren Bullaro Riker Principal Accounting Officer & Senior Vice President of Finance
Susan Mesco Head of Investor Relations

Latest SEC Filings

Date Type Title
Oct 30, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 30, 2026 SC 14D9 Filing
Oct 30, 2026 SC TO-T Filing
Oct 13, 2026 SC 13D/A [Amend] Filing
Oct 09, 2026 4 Filing
Oct 08, 2026 SC TO-C Filing
Oct 08, 2026 SC14D9C Filing
Oct 08, 2026 8-K Current Report
Oct 08, 2026 SC TO-C Filing
Aug 18, 2026 4 Filing
View All SEC Filings ➞
Pacira BioSciences
Pacira BioSciences logo
Country United States
IPO Date Feb 3, 2011
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 827
CEO Frank D. Lee

Contact Details

2000 Sierra Point Parkway Brisbane, California 94005 United States

Stock Details

Ticker Symbol PCRX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001396814
CUSIP Number 695127100
ISIN Number US6951271005
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.